CONMED
CNMD
226 hedge funds and large institutions have $2.42B invested in CONMED in 2019 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 90 increasing their positions, 64 reducing their positions, and 23 closing their positions.
87% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 23
51% more call options, than puts
Call options by funds: $2.75M | Put options by funds: $1.81M
41% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 64
38% more capital invested
Capital invested by funds: $1.75B → $2.42B (+$671M)
9% more funds holding
Funds holding: 207 → 226 (+19)
6.54% more ownership
Funds ownership: 96.76% → 103.3% (+6.5%)
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$42.7M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$27.6M |
| 3 |
HM
HealthCor Management
New York
|
+$24.7M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$23.4M |
| 5 |
Millennium Management
New York
|
+$18.1M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$62.2M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.5M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$10.1M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.45M |
| 5 |
BlackRock
New York
|
-$6.19M |
CNMD Hedge Fund Activity: Q1 2019 in Review
226 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2019, worth a combined $2.42B — up 38% from $1.75B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CNMD positions and 23 closed out — a net gain of 20 holders — while 90 added to existing stakes and 64 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $42.7M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $62.2M sold.
- 226 institutional investors held CONMED (CNMD) as of Q1 2019, up from 207 in Q4 2018.
- Funds reported $2.42B of CONMED stock for Q1 2019, up 38% quarter-over-quarter.
- 43 funds opened new CONMED positions in Q1 2019 and 23 closed out, a net change of +20 holders.
- The largest CONMED buyer in Q1 2019 was Point72 Asset Management, an estimated $42.7M added.
- The largest CONMED seller in Q1 2019 was Scopia Capital Management, an estimated $62.2M sold.
Based on aggregated 13F filings for Q1 2019.